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Edited by Frances ShannonAbstract An association between the MHC class II chaperone
molecule Invariant chain (Ii) and MHC class I molecules is
known to occur, but the basis of the interaction is undetermined.
Evidence is presented here that the CLIP region of Ii is involved
in this interaction. A peptide encoding residues 91–99 of CLIP
(MRMATPLLM) stabilised multiple MHC class I alleles, with
the methionine residue at position 99 having a crucial role in
binding to H2-Kb, whereas methionine at position 91 also ap-
peared important in binding to RT1-Aa. Ii can also be detected
in the class I MHC peptide loading complex. These data provide
an explanation for the association of Ii and MHC class I mole-
cules.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Major histocompatibility complex (MHC) class I molecules
normally assemble and bind peptide within the environment of
the endoplasmic reticulum (ER), resulting in the presentation
to CD8+ T lymphocytes of an endogenous pool of antigenic
peptides [1]. An unexpected interaction between the MHC
class II accessory molecule Invariant chain (Ii or CD74) and
MHC class I was ﬁrst described by Cerundolo and colleagues
[2]. Occurring in the ER, the interaction appears to require
essentially fully folded MHC class I, because free heavy chains,
or open conformations of MHC class I and b2-microglobulin
do not associate eﬃciently with Ii [3,4]. The Ii–MHC class I
interaction can also inﬂuence the cell surface expression level
of MHC class I [3,4], and result in its delivery to endocytic
compartments, where dissociation of the complex can be inhib-
ited in the presence of concanamycin B [5]. How Ii and MHC
class I interact has not been elucidated, however the observa-
tions that both speciﬁc MHC-class I binding peptides and
mutations within the peptide groove disrupt the interaction
suggest that the groove is directly involved [2–4].
The association of Ii with MHC class II molecules involves
the direct occupancy of the peptide-binding groove with a re-
gion of Ii known as the class II invariant chain derived peptide
(CLIP) [6,7]. CLIP prevents the loading of antigenic peptidesE-mail address: sjp10@st-andrews.ac.uk (S.J. Powis).
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is presented that the CLIP region is also directly involved in
the association of Ii with MHC class I molecules, and that this
can result in the inclusion of Ii in the MHC class I peptide-
loading complex.2. Methods
2.1. Cell and antibodies
T2, T2.B27 [8], T2.TAP1+2 [9], Daudi, .220.B8 (tapasin deﬁcient
.220 cells expressing HLA-B8, a gift from Paul Lehner, Cambridge,
UK and Eric Hewitt, Leeds, UK), RMA-S and RMA-S.Aa cells were
maintained in RPMI 1640 containing 5% FBS (Gibco). Human HEK
293 and Hela cells were maintained in DMEM containing 10% FBS.
Human blood monocyte derived dendritic cells (DC) were prepared
from buﬀy coat by positive selection with CD14 magnetic beads (Milt-
enyi Biotec), and culture in 1000 U/ml IL4 (Pharmingen) and 800 U/ml
GM-CSF (Sandoz) for 6 days. The following antibodies were used:
W6/32 (recognising folded HLA-A, -B and -C), VICY1 (human Ii),
HC10 (partially and fully unfolded HLA-B), BB7.2 (folded HLA-
A2), Y3 (folded H-2Kb), MAC30 (folded RT1-Aa), rabbit anti-human
tapasin (from Tim Elliott, Southampton, UK), rabbit anti-ERp57
(from Neil Bulleid, Manchester, UK), rabbit anti-rat TAP2, rabbit
anti-calreticulin (Stressgen).
2.2. Peptides and DNA
The following MHC binding and control peptides were used in sta-
bilisation experiments: A2 (LLDVPTAAV), B51 (LPPVVAKEI), B27
(GRAFVTIGK), control irrelevant peptide (TNKTVARYV),
CLIP(91–99) (MRMATPLLM), M91A (ARMATPLLM), M99A
(MRMATPLLA), M91/99A (ARMATPLLA). Peptides were stored
at 80 C at stock concentrations of 10 mM. Human Ii cDNA (from
Philippe Benaroch, Paris, France, and Colin Watts, Dundee, UK) in
expression vector pCDNA3 (Invitrogen) was mutagenised using
Quickchange (Stratagene) methodology, using primers 5 0-
cctgtgagcaaggcgcgcatggccacc-3 0 and 5 0-accccgctgctggcgcaggcgctgccc-
3 0 to generate Ii.M91A and Ii.M99A, respectively. Altered bases are
underlined and complementary primers are not shown. cDNAs encod-
ing HLA-B*0702 and B*3506 were a gift from Ann-Margaret Little
(London, UK). RT1-Aa cDNA was a gift from Geoﬀrey Butcher
(Cambridge, UK). 293 and Hela cells were transiently transfected with
2 lg plasmid DNA and 4 ll Fugene 6 (Roche) per 3.5 cm well.
2.3. Immunoprecipitations and immunoblotting
For metabolic labelling, cells were incubated with 3.7 MBq Trans la-
bel (ICN) for 15 min, then lysed in 1% Digitonin (Sigma), 1% CHAPS
(Roche), or 1% NP40 containing lysis buﬀer (150 mM NaCl, 10 mM
Tris, pH 7.5, 1 mM PMSF, 10 mM N-ethylmaleimide) as required.
Precleared lysates were immunoprecipitated with relevant antibodies
and Protein A and G Sepharose. Washed immunoprecipitates were
analysed by SDS–PAGE or two-dimensional gel electrophoresis as
previously described [10]. For pulse chase experiments cells were la-
belled as above, returned to normal medium and aliquots of cells re-
moved and lysed at the indicated times. For immunoblotting, cellsblished by Elsevier B.V. All rights reserved.
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analysed by SDS–PAGE, with whole-lysate tracks included as con-
trols. Resulting immunoblots were incubated with relevant primary
antibodies overnight at 4 C, followed by HRP coupled secondary
reagents and developed with Supersignal Femto chemiluminescent
reagents (Pierce).
2.4. Stabilisation assays
Peptide stabilisation of MHC class I molecules in detergent cell ly-
sates was performed based on Williams and colleagues [11]. Brieﬂy,
T2, T2.B27, transiently transfected HEK 293 cells, and RMA-S cells
were radiolabelled and lysed in NP40 lysis buﬀer, incubated with pep-
tides at 50 lM for 1 h on ice, then heated at between 24 and 37 C as
required for 1 h, or heated at 37 C for diﬀerent times, followed by
immunoprecipitation with relevant antibodies and analysis by SDS–
PAGE or two-dimensional gel analysis. Scanned autoradiographs were
analysed using NIH Image software. Control lysates without peptides
were incubated on ice or at 37 C as required.
Cell surface peptide stabilisation assays were performed using mur-
ine TAP2-deﬁcient RMA-S and RMA-S.Aa cells, based on Stevens and
colleagues [12]. Brieﬂy, RMA-S and RMA-S.Aa cells were incubated
for up to 48 h at 26 C to allow enhanced cell surface expression of
MHC class I. Cells were then resuspended in serum-free DMEM in
a 96-well plate with peptides at the indicated concentrations for 1 h
at 26 C. Cells were then returned to 37 C for 3 h to dissociate unsta-
ble and non-peptide loaded MHC class I molecules, followed by stain-
ing with relevant antibodies and analysis by ﬂow cytometry. Mean
ﬂuorescent indexes were used to determine the percent stabilisation,
with 100% stabilisation being that obtained with the highest concentra-
tion of peptide CLIP(91–99).Fig. 1. Association of Ii with MHC class I. (A) Two-dimensional gel
analysis of digitonin lysates of radiolabelled T2 cells reveals the
presence of HLA-A2 and -B51 alleles immunoprecipitated with W6/32.
VICY1 (anti-Ii) reveals the co-precipitation of HLA-B51 heavy chains
and b2-microglobulin (arrowheads). (B) Immunoblotting with HC10
(anti-HLA-B heavy chains) of VICY1 immunoprecipitates of digitonin
lysates reveals the Ii–MHC class I interaction requires b2-microglob-
ulin (Daudi), but not tapasin (.220.B8).3. Results and discussion
3.1. The Ii–MHC class I interaction
The Ii–MHC class I interaction in human TAP-deﬁcient T2
cells is shown in Fig. 1A, where two-dimensional gel analysis
of immunoprecipitates from digitonin lysates of metabolically
labelled cells revealed the MHC class I alleles expressed in T2
(HLA-A2 and -B51, both b2m-associated) isolated by mAb
W6/32 (middle panel), and the presence of B51 co-precipitating
(arrowheads, lower panel) with Ii (mAb VICY1). Longer expo-
sure also revealed the presence of A2 (data not shown). By
immunoprecipitation of Ii and immunoblotting for MHC class
I the Ii–MHC interactions in relation to previous observations
was also conﬁrmed [3]; Ii–MHC class I complexes were not de-
tected in b2-microglobulin deﬁcient Daudi cells, but were able
to form in tapasin-deﬁcient .220.B8 cells (Fig. 1B).
3.2. CLIP peptide stabilisation of MHC class I
The CLIP region contains a central nine amino acid se-
quence, MRMATPLLM, which is conserved in human, mouse
and rat (Fig. 2A). The location of an arginine as the second
residue in this sequence suggested this peptide could be able
bind to HLA-B27, which has a strong preference for arginine
at P2 [13]. A synthetic peptide of this region, CLIP(91–99),
was therefore compared to known A2, B51 and B27 binding
peptides for the ability to stabilise MHC class I in radiola-
belled cell lysates of T2 cells transfected with B27 (T2.B27).
Lysates preincubated with 50 lM of the relevant peptide were
heated at 37 C for 1 h to dissociate non-peptide loaded MHC
class I, followed by immunoprecipitation with W6/32 and two-
dimensional gel analysis (Fig. 2B). Unexpectedly, whereas the
allele-speciﬁc peptides stabilised their relevant molecule, the
CLIP(91–99) peptide weakly, but signiﬁcantly, stabilised both
A2, B51 and B27 molecules. CLIP(91–99) was also able to sta-
bilise HLA-B7, B35 and rat RT1-Aa class I molecules tran-siently expressed in HEK 293 cells (Fig. 2C). Treatment of
T2 lysates at increasing temperatures revealed the consistent
ability of CLIP(91–99) to partially stabilise HLA-A2 molecules
(Fig. 2D). Similar results were obtained for H-2Kb and RT1-
Aa alleles (not shown). Incubation at 37 C of detergent lysates
of the RMA-S cell line preincubated with the CLIP(91–99)
peptide, followed by immunoprecipitation of folded H-2Kb
molecules with mAb Y3 indicated that CLIP(91–99) stabilised
Kb for between 5 and 15 min. Taken together these data there-
fore suggest that CLIP(91–99) has a weak aﬃnity for a wide
range of MHC class I alleles, possibly reﬂecting the similar
ability of the CLIP region to associate with a wide range of
MHC class II alleles.
3.3. Role of methionine at position 91 and 99 in binding
Analysis of MHC class II supermotifs [14] and the crystal
structures of CLIP complexed with MHC class II molecules
[6,7] indicate the importance of methionine residues at posi-
tions 91 and 99 in the binding of CLIP. To assess if these res-
idues were also important in the binding of CLIP(91–99) to
MHC class I, peptides were synthesized in which the ﬁrst, last,
Fig. 2. CLIP(91–99) stabilises multiple MHC class I alleles. (A) Ii sequence alignment of human (Accession No. 10835070), mouse (13097485) and
rat (37589621) indicates conservation of CLIP(91–99) region (bold). (B) Detergent lysates of radiolabelled T2.B27 cells, incubated with allele-speciﬁc
peptides (A2:LLDVPTAAV, B51:LPPVVAKEI, B27:GRAFVTIGK) and CLIP(91–99) demonstrate stabilisation of HLA-A2, -B51 and -B27 by
CLIP(91–99). (C) HLA-B7, -B53 and rat RT1-Aa are stabilised by CLIP(91–99) in transiently transfected 293 cells. (D) Temperature titration of
CLIP(91–99) stabilisation of HLA-A2 in T2 cells. Detergent lysates of T2 cells were incubated with A2-binding peptide (LLDVPTAAV) or CLIP(91–
99), heat treated and immunoprecipitated with mAb BB7.2 (anti-HLA-A2). (E) Time course of CLIP(91–99) stabilisation of H2-Kb molecules.
Detergent lysates of radiolabelled murine RMA-S cells were preincubated with 50 lM CLIP(91–99) and then incubated at 37 C for the indicated
times, and Kb immunoprecipitated with mAb Y3.
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tides M91A, M99A and M91/99A, respectively). These pep-
tides were then tested for their ability to stabilise H-2Kb
molecules on the cell surface of TAP2-deﬁcient RMA-S cells
which had been incubated overnight at 26 C to allow cell sur-
face expression of empty, or low aﬃnity loaded Kb molecules
[15]. After incubation with peptides, the cells were returned to
37 C to induce dissociation of non-peptide loaded Kb mole-
cules, and stabilisation determined by ﬂow cytometry [12].
Substitution of methionine at position 91 did not appreciably
alter the ability of peptide M91A to stabilise Kb, however sub-
stitution of methionine at position 99 dramatically reduced
binding to Kb (Fig. 3A). Thus, the C-terminal methionine in
CLIP(91–99) appears to act as an anchor residue for H-2Kb.
Somewhat in contrast to these results, when similar studies
were performed on RT1-Aa in transfected RMA-S.Aa cells,
the loss of methionine at position 91 also aﬀected the eﬃciency
of peptide stabilisation. Thus diﬀerent MHC class I alleles dis-
play diﬀerent dependencies upon the sequence of CLIP in or-
der to become weakly stabilised.
In contrast to MHC class II, the peptide groove of MHC
class I is essentially closed at either end, normally only allow-
ing eﬃcient binding of peptides in the range of 8–10 residues.
Therefore it was pertinent to ask whether the residues identi-
ﬁed above were also relevant to interactions of full-length Ii
with MHC class I. Site-directed mutagenesis of Ii cDNAwas performed to alter the methionine at positions 91 and
99 to alanine (constructs Ii.M91A and Ii.M99A, respectively).
Hela cells were transiently transfected with the Ii constructs,
radiolabelled and CHAPS lysates immunoprecipitated with
W6/32 and VICY1 (Fig. 3B). Mutation of the methionine at
position 99 resulted in a weakened interaction of Ii and
MHC class I molecules. A pulse-chase experiment was also
performed using a 15-min label and up to 90-min chase, fol-
lowed by immunoprecipitation with W6/32, which demon-
strated that the Ii–MHC class I interaction was lost between
45 and 90 min chase, suggesting that the molecules dissociated
at a later stage of transport and after exit from the ER
(Fig. 3C). Although digestion with endoglycosidase H was
not performed in this experiment, a small increase in molecu-
lar mass is visible in the MHC class I heavy chain after
45 min, corresponding to post-ER modiﬁcation of the glycan
structure, and therefore supporting exit from the ER whilst
still attached to Ii.
3.4. Inclusion of Ii in the MHC class I peptide-loading complex
The ability of Ii to interact with MHC class I through bind-
ing of CLIP to the peptide groove suggested that it may be able
to incorporate in to the MHC class I peptide loading complex
(PLC), which comprises MHC class I/b2-microglobulin, calret-
iculin, the oxidoreductase ERp57, the accessory molecule tapa-
sin, and the peptide transporter TAP [1]. This multimolecular
Fig. 3. Methionine at positions 91 and 99 are important in CLIP-binding to MHC class I. (A) Cell surface stabilisation of H2-Kb on RMA-S cells,
and RT1-Aa on transfected RMA-S.Aa cells. Substitution of Met99, but not Met91, prevents stabilisation of Kb molecules, whereas RT1-Aa was
aﬀected by loss of both methionine residues. (B) Substitution of Met99 in full length Ii cDNA prevents association with MHC class I. Hela cells were
transiently transfected with the indicated Ii cDNA, radiolabelled, and CHAPS lysates immunopecipitated with W6/32 or VICY1. UT: untransfected
control. (C) Transiently transfected Hela cells were pulse radiolabelled, chased in the absence of label for the indicated times, lysed and
immunoprecipitated with W6/32.
Fig. 4. (A) Association of Ii with the MHC class I peptide-loading
complex (PLC). Digitonin lysates of T2 and T2.TAP1+2 cells were
immunoprecipitated with VICY1. Blots were probed with antibodies
recognising MHC class I heavy chains (MHC I HC: HC10), tapasin
(TPN), ERp57, TAP2 and calreticulin (CRT). (B) Human blood
monocyte derived DC were metabolically radiolabelled, lysed in
CHAPs and immunoprecipitated with W6/32, VICY1, or a control
with no antibody.
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ciates allowing transport of the MHC class I molecule out of
the ER. Digitonin lysates of T2 cells were therefore immuno-
precipitated with VICY1 and resulting blots probed for the
presence of PLC components (Fig. 4A). Both tapasin and
ERp57 were also found in the immunoisolated complexes.
No TAP2 was detected in these TAP deﬁcient cells. Calreticu-
lin was also detected, however calreticulin associates indepen-
dently with Ii during its assembly in the ER (data not shown).
In T2 cells transfected with TAP1 and TAP2, the interaction of
Ii with the PLC is signiﬁcantly reduced, most likely due to the
fully functioning loading pathway in the these cells [9], how-
ever very weak interactions could reproducibly be detected
for tapasin, ERp57 and also TAP2. Taken together, these data
indicate that Ii can incorporate into the MHC class I PLC, but
is usually prevented from doing so by the presence of peptides
that are suitable for MHC class I binding.
The exact role of tapasin in the PLC, as a peptide editor or
peptide facilitator [16], remains to fully established, however
the inclusion of Ii in the PLC as reported here, with the possi-
ble occupation of the MHC class I groove by CLIP, suggests
that tapasin therefore does not directly interact with the pep-
tide groove, or can be precluded from doing so by the presence
of Ii. Intriguingly, the amino-terminal domain of tapasin con-
tains a similarly proline-rich sequence as Ii [17], though no
apparent direct sequence homology exists, and a synthetic pep-
tide of this region did not stabilise MHC class I molecules in
heat-treated cell lysates (data not shown).
3116 S.J. Powis / FEBS Letters 580 (2006) 3112–3116The CLIP(91–99) region is, as shown in Fig. 2A, completely
conserved between human, mouse and rat. This striking con-
servation does not extend to other species, although the key
methionine at position 99 does appear to be highly conserved
[18]. Further studies may establish whether the CLIP region of
other species also has an aﬃnity for MHC class I molecules, or
whether human, mouse and rat are unique in this respect.
3.5. Ii–MHC class I interaction in DC
A physiological function of the Ii–MHC class I interaction
has not been established. Cross presentation by dendritic cells,
whereby peptides of an exogenous nature can be loaded onto
MHC class I, has been reported to occur by the formation
of ER-derived phagosomes, and the recycling of MHC class
I from the cell surface into the endocytic pathway [19–21].
The Ii-directed delivery of MHC class I to endosomes could
also supplement cross presentation. It was therefore investi-
gated if the Ii–MHC class interaction formed in human mono-
cyte derived dendritic cells. Immunoprecipitation with W6/32
and VICY1 of radiolabelled cells suggests that the Ii–MHC
class I interaction does indeed form in this important popula-
tion of cells (Fig. 4B), and may therefore provide a direct rout-
ing of new MHC class I molecules to endocytic compartments
[5].
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